Sex hormone-binding globulin
SHBGproteinSHBG is a systemic CAD-risk modifier that regulates sex-hormone bioavailability and influences metabolic and vascular health independent of atherothrombotic cascade steps.
Pathway placement
Cascade stepOff-pathway / systemic markers
Confidencemedium
RationaleSystemic CAD risk modifier; endocrine/metabolic axis; not direct cascade step.
Druggability
Not assessed (no mapped human gene target).
Type I vs Type II discrimination
ScoresLow-confidence (proxy)
R — rupture / Type-I59
C — confounder / Type-II59
A — assay feasibility68
E — evidence strength25
T1DI (composite)9
Specificity differential (R−C)+0.8
Confounder panel (Type-II drivers)
No confounder evidence retrieved.
Tier: light (literature co-occurrence proxy — lower confidence). See the discrimination table for all markers.
Assay & specimen
Class-level default (no specific cleared assay)— generic method inferred from analyte class; confirm against a specific product insert before use.
Specimen
Serum or plasma
Collection tube
Serum separator (gold/red-top, SST) · K2/K3-EDTA (lavender-top)
Method / principle
Sandwich immunoassay (ELISA) — research-grade unless a cleared assay exists
Reagent / substrate
Matched anti-target antibody pair (capture + labeled detection)
Platform
ELISA microplate or multiplex (Luminex/MSD)
Turnaround · availability
Send-out / research · Research-grade (no universal clinical assay)
Literature evidence(1)
- Genome-Wide European Ancestry Study Identifies Coronary Artery Disease-Associated Loci Through Gene-Sex Hormone Interaction.Journal of the American Heart Association · 2024 · PMID 39673284 · doi